Characterization of a novel and spontaneous mouse model of inflammatory arthritis by Cuzzocrea, Salvatore
Mouse model of rheumatoid arthritis
Adipue and colleagues [1] have characterized the novel 
IIJ (inherited inﬂ  amed joints) mouse strain, a new murine 
model of inﬂ  ammatory, possibly autoimmune, arthritis 
that is similar both histologically and serologically to 
human rheumatoid arthritis (RA) and other murine 
models of autoimmune arthritis [1]. RA is a chronic and 
progressive inﬂ  ammatory disorder characterized by syno-
vitis and severe joint destruction. Th   e pathogenesis of RA 
is a complex process, involving synovial cell proliferation 
and ﬁ  brosis, pannus formation, and cartilage and bone 
erosion [2]. Rodent models of RA have been used exten-
sively   to evaluate potential new therapeutic agents.
Arthritis in the mouse can be induced, can occur 
spontaneously in some inbred strains, or can result from 
single gene mutations (Table 1). Induced murine arthritis 
models include immunization with type II collagen 
(DBA/1LacJ), or treatment with pristane (BALB/c), 
thymo  cytes (C3H/He), mycoplasma (CBA), or a high fat 
diet (C57BL). Spontaneous models can be grouped 
according to their origin: development of autoimmune-
prone strains by selective mixing of previously existing 
inbred strains (for example, the MRL/lpr strain [3]); 
targeted gene manipulation (for example, the TCR trans-
genic K/BxN model [4], TNF-α overexpression models 
[5], the IL-1Ra knock-out model [6], and the gp130Y759F-
induced mutant); and identiﬁ   cation of spontaneous 
mutants from breeding colonies (for example, SKG mice 
with a point mutation in Zap-70 [7]).
Despite the existence of all of these models, it is well 
known that no animal model represents RA in its 
entirety. In addition, clinical manifestations are diﬀ  erent 
between diﬀ   erent strains of mice, even if the same   
induction protocol is employed, and some of the strains 
are even selected because of their susceptibility to auto-
immunity. Even though it is improbable that a single 
animal model could assume and reproduce human 
disease in its entirety and consistently, animal models 
have allowed us to understand common principles of the 
induction and persistence of inﬂ  ammatory processes and 
the pathways involved in cartilage and bone erosion and, 
therefore, have helped identify new therapeutic targets 
(Table 2).
Characterization of a novel and spontaneous 
mouse model of infl  ammatory arthritis
Adipue and colleagues [1] describe a new strain of mouse 
that spontaneously develops a chronic inﬂ  ammatory, 
possibly autoimmune, arthritis that shares many simi  lari-
ties with human RA and other mouse models of arthritis. 
Th   e authors point out that arthritis incidence in IIJ mice 
also displays the sex bias common to many complex 
autoimmune diseases such as RA, multiple sclerosis, and 
systemic lupus erythematosus [8]. Th   e sex bias appears to 
be speciﬁ  c for the arthritis phenotype since the incidence 
of typhlocolitis was similar between male and female IIJ 
mice. As most models reach 100% incidence in both 
sexes, no other spontaneous mouse model of arthritis has 
displayed such a sex bias, although more severe arthritis 
Abstract
Arthritis is a heterogeneous disease comprising 
a group of infl  ammatory and non-infl  ammatory 
conditions that can cause pain, stiff  ness and swelling 
in the joints. Mouse models of rheumatoid arthritis (RA) 
have been critical for identifying genetic and cellular 
mechanisms of RA and several new mouse models 
have been produced. Various methods have been 
applied to induce experimental models of arthritis in 
animals that would provide important insights into the 
etiopathogenetic mechanisms of human RA. Adipue 
and colleagues recently discovered that mice in their 
breeding colony spontaneously developed infl  amed 
joints reminiscent of RA and may, therefore, have found 
a new model to examine pathogenic mechanisms 
and test new treatments for this human infl  ammatory 
disease.
© 2010 BioMed Central Ltd
Characterization of a novel and spontaneous 
mouse model of infl  ammatory arthritis
Salvatore Cuzzocrea*
EDITORIAL
*Correspondence: salvator@.unime.it
Department of Clinical and Experimental Medicine and Pharmacology, School 
of Medicine, University of Messina, Torre Biologica, Policlinico Universitario, 
Via C. Valeria, Gazzi, 98100 Messina, Italy
Cuzzocrea Arthritis Research & Therapy 2011, 13:126 
http://arthritis-research.com/content/13/5/126
© 2011 BioMed Central Ltdin females has been reported for both the SKG [7] and 
gp130Y759F models [9]. A female bias in incidence was 
also observed in collagen-induced arthritis in humanized 
HLA-DR4-transgenic mice [10] and was attributed to 
both hyperactive B cells and HLA-DR4 restricted antigen 
presentation in female mice and increased numbers of T 
and B regulatory cells in male mice [11]. In particular, 
Adipue and colleagues emphasize that the histopathology 
in IIJ mice is similar to that described in previously 
published mouse models of autoimmune arthritis [7,9]. In 
addition, the predominantly neutrophilic and lymphocytic 
inﬁ  ltration into the inﬂ  amed IIJ joints parallels the large 
numbers of neutrophils and T cells present in the 
inﬂ  amed synovial ﬂ  uid of RA patients [12]. Finally, the IIJ 
mice also share serological similarities with RA and some 
other mouse models.
Conclusion
Adipue and colleagues have identiﬁ  ed the IIJ   strain as a 
new murine model of inﬂ   ammatory, possibly auto-
immune, arthritis. Th   e IIJ strain is similar both 
histologically and serologically to RA and other murine 
models of auto  immune arthritis. Moreover, the increased 
incidence of arthritis in female IIJ mice makes it a 
potentially impor  tant model to study the underlying 
causes of sex bias in autoimmunity.
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Table 1. Animal models of arthritis
Model   Abbreviation  Species  Feature
Induced models     
  Non-specifi  c immune stimuli     
    Adjuvant-induced arthritis  AA  Lewis rat  Autoimmune
    Oil-induced arthritis  OIA  DA rat  Autoimmune
    Pristane-induced arthritis  PIA  DA ra  Autoimmune
  Cartilage directed autoimmunity     
    Collagen-induced arthritis  CIA  DBA mouse  CII AI
    Proteoglycan-induced arthritis  PGIA  Balb/c mouse  PG AI
  Infectious agents/exogenous triggers     
    Streptococcal cell wall arthritis  SCW-A  Lewis rat  Persistent bacteria AI
  Flare  SCW-F  Mouse  Th17
    Antigen-induced arthritis  AIA  Rabbit, mouse  Persistent antigen
  Flare  AIA-F  Mouse  Th17
   
Transgenic spontaneous models     
  HTLV-induced arthritis  HTLV  Mouse  Viral tax antigen
  KRN arthritis  KRN  K/BxN mouse  GPI AI
  SKG arthritis  SKG  Mouse  ZAP-70 T cell defect
  GP130 arthritis  GP130  Mouse  STAT3, T cell defect
  TNF transgenic arthritis  TNFtg  Mouse  TNF overexpression
  IL-1ra transgenic arthritis  IL-1ra-/-  Balb/c mouse  Autoimmune T cells
  IL-1 transgenic arthritis  IL-1tg  Mouse  IL-1 overexpression
   
Immune complex models     
  Collagen type II  CAIA  DBA mouse  Mouse CII antibody
  KRN serum  GPI  Balb/c mouse  Mouse GPI antibody
  Poly-L-lysine-lysozyme  PLL-L  DBA mouse  Cationic antigen
   
New animal model     
 Spontaneous     
    Inherited infl  amed joints strain  IIJ  Arthritic male mouse crossed   Autoimmune arthritis (for
        with SJL/J females  understanding the female bias) 
AI, autoimmunity; CII, collagen type II; GPI, glucose-6-phosphate isomerase; HTLV, human T-lymphotropic virus; IL, interleukin; KRN, C57Bl/6 mice carrying the KRN 
transgene heterozygously; PG, proteoglycan; SKG, SKG strain, derived from closed breeding colony of BALB/c mice, spontaneously develops chronic arthritis; TNF, 
tumor necrosis factor.
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Table 2. Drugs used to treat arthritis
Type of drug  Name of drug  Use
Drugs that aff  ect symptoms of the disease (analgesics)  Acetaminophen  Relieves pain
    Aspirin  Reduces infl  ammation and relieves pain
  
Oral nonsteroidal anti-infl  ammatory drugs (NSAIDs)  Diclofenac  Reduces infl  ammation and relieves pain
    Difl  unisal, etodolac, fenoprofen, fl  urbiprofen,   All NSAIDs treat the symptoms and decrease
    ibuprofen, indomethacin, ketoprofen,   infl  ammation but do not alter the course of
    meclofenamate, mefenamic acid, meloxicam,   the disease
    nabumetone, naproxen, oxaprozin, 
    phenylbutazone, piroxicam, sulindac, tolmetin
  
COX-2 inhibitors  Celecoxib, valdecoxib  Reduces infl  ammation and relieves pain
  
Narcotic/analgesics Propoxyphene  Relieves  pain
   Tramadol  Relieves  pain
  
Corticosteroids  Methylprednisolone, prednisone, injectable   Suppresses infl  ammation in severe organ 
    corticosteroids  disease or life-threatening disease
Disease-modifying antirheumatic drugs (DMARDs)a  Auranofi  n (oral gold), cyclosporine, gold salts   All DMARDs can slow progression of joint
    (injectable), hydroxychloroquine, lefl  unomide,   damage as well as gradually decrease pain and
    methotrexate, penicillamine, sulfasalazine  swelling
  
Biologics  
  Anti-TNF compounds  Adalimumab, etanercept, infl  iximab,   Suppresses infl  ammation and inhibit the
    certolizumab, golimumab   progress of joint damage
 IL-1  inhibitor  Anakinra  Treats moderate to severe RA in people who do 
      not respond to DMARDs
  B-cell-depleting agent  Rituximab  Treats RA unresponsive to TNF inhibitors
  T-cell co-stimulation antagonist  Abatacept  Treats RA unresponsive to DMARD therapy
  IL-6 antagonist  Tocilizumab  Treats RA unresponsive to TNF inhibitors
COX, cyclooxygenase; DMARD, disease-modifying anti-rheumatic drug; IL, interleukin; RA, rheumatoid arthritis; TNF, tumor necrosis factor.
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